Dykes Carrie, Gardner Cody, Chang Jack, Pinto David, Wilson Karen, Zand Martin S, Dozier Ann
Clinical and Translational Science Institute, School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA.
Department of Pediatrics, School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA.
J Clin Transl Sci. 2024 Oct 14;8(1):e160. doi: 10.1017/cts.2024.605. eCollection 2024.
Recruitment of participants into research studies remains a major concern for investigators. Using clinical teams to identify potentially eligible patients can present a significant barrier. To overcome this, we implemented a process for using our patient portal, called MyChart, as a new institutional recruitment option utilizing our electronic health record's existing functionality.
To streamline the institutional approval process, we established a working group comprised of representatives from human subject protection, information technology, and privacy and vetted our process with many stakeholder groups. Our specific process for study approval is described and started with a consultation with our recruitment and retention function funded through our Clinical and Translational Science Award.
The time from consultation to the first message(s) sent ranged from 84 to 442 days and declined slightly over time. The overall patient response rate to MyChart messages about available research studies was 23% with one third of those saying they were interested in learning more. The response rate for Black and Hispanic patients was about 50% that of White patients.
Many different types of studies from any medical specialty successfully identified interested patients using this option. Study teams needed support in defining appropriate inclusion/exclusion criteria to identify the relevant population in the electronic health records and they needed assistance writing study descriptions in plain language. Using MyChart for recruitment addressed a critical barrier and opened up the opportunity to provide a full recruitment consultation to identify additional recruitment channels the study teams would not have considered otherwise.
研究人员招募研究参与者仍然是一个主要问题。利用临床团队来识别潜在符合条件的患者可能会构成重大障碍。为了克服这一问题,我们实施了一个流程,即利用名为MyChart的患者门户,作为一种新的机构招募选项,利用我们电子健康记录的现有功能。
为了简化机构审批流程,我们成立了一个由来自人类受试者保护、信息技术以及隐私方面的代表组成的工作组,并与许多利益相关者团体对我们的流程进行了审核。我们描述了具体的研究审批流程,该流程始于与通过我们的临床和转化科学奖资助的招募与保留职能部门进行的磋商。
从磋商到发送第一条信息的时间为84至442天,且随着时间推移略有下降。患者对MyChart关于可用研究的信息的总体回复率为23%,其中三分之一的人表示有兴趣了解更多。黑人和西班牙裔患者的回复率约为白人患者的50%。
来自任何医学专业的许多不同类型的研究都通过此选项成功识别出了感兴趣的患者。研究团队在确定合适的纳入/排除标准以在电子健康记录中识别相关人群方面需要支持,并且在以通俗易懂的语言撰写研究描述方面需要协助。使用MyChart进行招募解决了一个关键障碍,并为提供全面的招募咨询以识别研究团队原本不会考虑的其他招募渠道创造了机会。